Click to zoom
Product Description
Herduo 250 mg Tablets (containing the active ingredient Lapatinib I.P.) are a targeted anti-cancer medication prescribed for the treatment of advanced or metastatic HER2-positive breast cancer. Manufactured by Natco Pharma, it works by inhibiting the overproduction of EGFR and HER2 proteins to slow or stop cancer cell growth.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Packaging Size 30 Tablets
Strength 250 mg
Pack Size 30 Tablets
Form Tablet
Usage HER2+ Breast Ca, Breast Cancer
Manufactured By Natco
Country of Origin Made in India
Composition Lapatinib Tablets IP
Brand Herduo
Packaging Type Box
Treatment Breast cancer
Minimum order quantity: 50 Bottle
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
500 mg CIPRODAC 500 CIPROFLOXACIN IP TABLETS
On Request
500 mg Ciplox-500 Ciprofloxacin Hydrochloride IP Tablets
On Request
12 mg Iverheal 12 Ivermectin Dispersible Tablets
On Request
500 mg Novamox-500 Amoxycillin Trihydrate IP Capsules
On Request
500 mg Methoflam-500 Methocarbamol IP Tablets
On Request
25 mg Baclosign-25 Baclofen Tablets
On Request
25 mg LENANAMO Lenalidomide Capsules
On Request
500 mg Captomer MERCAPTOPURINE I.P. TABLETS
On Request